Health Canada has approved AstraZeneca’s antibody combination to prevent symptomatic COVID\u002D19 infection in immunocompromised people.
The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won’t provide enough immunity.“Both the Public Health Agency of Canada and Health Canada continue to strongly recommend up-to-date vaccination for all eligible Canadians,” Health Canada said in a news release Thursday.
“For vulnerable populations, such as those who are immune-compromised, Evusheld helps to address an unmet need in the ongoing fight against COVID-19,” said Kiersten Combs, president of AstraZeneca Canada.Health Canada has placed conditions on the drug’s approval, including a requirement for AstraZeneca to continuously provide updated information on the safety and efficacy of the antibody combination.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
California health officials: Asymptomatic people exposed to COVID don't need to quarantineCalifornia health officials now say asymptomatic people who are exposed to COVID-19 do not need to quarantine anymore.
Leer más »
Reykdal: Board of Health 'landed in right place' by not mandating COVID vaccine for studentsSuperintendent Chris Reykdal explains the reason behind the Board of Health not requiring the COVID-19 vaccine for students this fall.
Leer más »
Colorado’s COVID public health order extended a month, but you probably won’t noticeThe Colorado Department of Public Health and Environment extended its public health order meant to combat COVID-19 on Thursday, but it won’t have much effect on most residents unless the virus starts spreading more widely.
Leer más »
COVID-19 cases rising across Illinois, health officials warnThe Illinois Department of Public Health issued a warning Thursday that COVID-19 cases are slowly rising across the state.
Leer más »
Public health expert talks about effectiveness of a second COVID-19 vaccine boosterICYMI on KPBS Midday Edition: A new study published in the New England Journal of Medicine Wednesday evaluated the early effectiveness of a second COVID-19 vaccine booster for people over the age of 60.
Leer más »
WA Board of Health votes 'no' on including COVID vaccine in child immunizationsThe Washington Board of Health voted to not include the COVID-19 vaccine as a required immunization for kids going to school. FOX13
Leer más »